Micro-X Limited (ASX:MX1)
0.0670
+0.0010 (1.52%)
Apr 28, 2025, 3:33 PM AEST
Micro-X Revenue
Micro-X had revenue of 7.40M AUD in the half year ending December 31, 2024, a decrease of -7.82%. This brings the company's revenue in the last twelve months to 14.13M, down -8.69% year-over-year. In the fiscal year ending June 30, 2024, Micro-X had annual revenue of 15.22M with 1.45% growth.
Revenue (ttm)
14.13M
Revenue Growth
-8.69%
P/S Ratio
3.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
43.84M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 15.22M | 217.00K | 1.45% |
Jun 30, 2023 | 15.01M | 6.04M | 67.28% |
Jun 30, 2022 | 8.97M | 5.20M | 137.87% |
Jun 30, 2021 | 3.77M | -480.00K | -11.29% |
Jun 30, 2020 | 4.25M | 2.32M | 120.15% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |